choosing between cpx-351 and flag-ida in newly diagnosed and r/r aml
Published 6 months ago • 111 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:05
safety and efficacy of cpx-351 in newly diagnosed aml patients under the age of 60
-
1:02
aml19: flag-ida vs cpx-351 in patients with aml with adverse risk cytogenetics
-
3:26
aml19 trial: flag-ida-go vs da-go in standard-risk aml and flag-ida vs cpx-351 in high-risk aml
-
2:01
analyzing the cost-effectiveness of cpx-351 in patients with aml
-
3:11
intensive chemotherapy: why the modern approach of cpx-351 is important for cure in aml
-
4:22
icount 3ts - 3 part hematology system 7 reasons for you to choose ! 70 tests per hour !
-
3:55
what is a complete blood count, and how frequently will my doctor monitor this? #aml
-
4:53
what is consolidation therapy? #aml
-
1:54
what are the lab abnormalities you will usually see in newly diagnosed aml? #aml
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
2:21
cpx-351 for high-risk aml
-
2:45
what does the term genetics mean, and why is it relevant to patients with aml? #aml
-
1:19
predicting the outcomes of patients with aml treated with cpx-351 based on eln risk stratification
-
3:07
improved understanding of cpx-351 in aml: impact of hct & final eap results
-
2:59
genetic subtypes of aml that are more likely to respond to cpx-351
-
1:30
evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
-
2:16
cpx-351 in poor risk aml patients
-
1:30
the current role of cpx-351 in aml and clinical trials evaluating this agent
-
3:48
cpx-351 for secondary aml: pharmacokinetics, administration & impact on treatment
-
2:11
regulatory approval of cpx-351 for secondary aml
-
2:42
which tests do you need before deciding on an aml treatment path?
-
2:29
cpx-351 vs 7 3 in older high-risk aml patients